Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EZM0414 is a potent, selective, orally bioavailable inhibitor of SETD2 with IC50 of 18 nM in SETD2 biochemical assay and IC50 of 34 nM in a cellular assay. EZM0414 can be used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 64,000 |
5 mg | 在庫あり | ¥ 158,000 |
10 mg | 在庫あり | ¥ 224,500 |
25 mg | 在庫あり | ¥ 335,000 |
50 mg | 在庫あり | ¥ 450,000 |
100 mg | 在庫あり | ¥ 608,500 |
説明 | EZM0414 is a potent, selective, orally bioavailable inhibitor of SETD2 with IC50 of 18 nM in SETD2 biochemical assay and IC50 of 34 nM in a cellular assay. EZM0414 can be used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma [1]. |
分子量 | 400.49 |
分子式 | C22H29FN4O2 |
CAS No. | 2411748-50-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 115 mg/mL (287.15 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EZM0414 2411748-50-8 Chromatin/Epigenetic Histone Methyltransferase EZM 0414 EZM-0414 Inhibitor inhibitor inhibit